01 1Aarti Drugs
01 1RIVASTIGMINE HYDROGEN TARTRATE
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2015-04-06
Pay. Date : 2014-05-09
DMF Number : 22997
Submission : 2009-07-31
Status : Active
Type : II
20
Aarti Drugs Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is RIVASTIGMINE HYDROGEN TARTRATE, with a corresponding US DMF Number 22997.
Remarkably, this DMF maintains an Active status since its submission on July 31, 2009, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 06, 2015, and payment made on May 09, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II
